Testing Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced Chondrosarcoma

Clinical trial NCT04458922 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04458922
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Central Chondrosarcoma, Grade 2 Central Chondrosarcoma, Grade 3 Dedifferentiated Chondrosarcoma Metastatic Clear Cell Sarcoma of Soft Tissue Metastatic Primary Central Chondrosarcoma Unresectable Primary Central Chondrosarcoma

Start date: 2020-10-05
Primary completion: 2022-11-28
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.